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OBJECTIVE: Hypoalbuminemia is a common clinical deficiency in burn patients and is associated with
complications related to increased extravascular fluid, including edema, abnormal healing, and susceptibility to
sepsis. Some prognostic scales do not include biochemical parameters, whereas others consider them together
with comorbidities. The purpose of this study was to determine whether serum albumin can predict mortality in
burn patients.
METHODS:We studied burn patients$16 years of age who had complete clinical documentation, including the
Abbreviated Burn Severity Index, serum albumin, globulin, and lipids. Sensitivity and specificity analyses were
performed to determine the cut-off level of albumin that predicts mortality.
RESULTS: In our analysis of 486 patients, we found that mortality was higher for burns caused by flame
(p=0.000), full-thickness burns (p=0.004), inhalation injuries (p=0.000), burns affecting .30% of the body
surface area (p=0.001), and burns associated with infection (p=0.008). Protein and lipid levels were lower in
the patients who died (p,0.05). Albumin levels showed the highest sensitivity and specificity (84% and 83%,
respectively), and the area under the receiver-operating characteristic curve (0.869) had a cut-off of 1.95 g/dL
for mortality.
CONCLUSION: Patients with albumin levels ,2 g/dL had a mortality risk of .80%, with 84% sensitivity and 83%
specificity. At admission, the albumin level could be used as a sensitive and specific marker of burn severity and
an indicator of mortality.
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& INTRODUCTION
From 2004 to 2008, the Mexican National Health Information
System (SINAIS) reported 65,896 discharges of patients affected
by burn injuries from national public institutions, 64,606
(98.04%) of which were attributed to morbidity and 1,290
(1.96%) to mortality. During the same period, SINAIS also
reported a total of 3,795 discharges from public institutions in
the state of Jalisco, Mexico, 3,736 of which (98.44%) were
attributed to morbidity and 59 (1.6%) to mortality (1,2).
Globally, advances in treating burns have significantly
changed the clinical course of a patient’s recovery, increas-
ing the chance of survival. However, the mortality rate
remains high, and the probability of death can be predicted
from clinical factors (3–5).
Evaluating the risk of death in burn patients is essential
for their overall treatment and selecting and improving their
future management regimens (4). The use of prognostic
factors has been attempted in these patients, and several
scales, such as the Abbreviated Burn Severity Index (ABSI),
which includes variables such as sex, age, total burned body
surface area (BSA), full-thickness injuries, and burns
attributable to inhalation (6), have been implemented but
do not include biochemical variables. The Acute Physiology
and Chronic Health Evaluation (APACHE) II and APACHE
Copyright  2013 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2013(07)09
CLINICAL SCIENCE
940
III scales include serum albumin levels and comorbidities to
improve predictive power (7).
Hypoalbuminemia is common in critically ill patients,
particularly in burn patients (8). Even when burns cover
,10% of the body surface, important metabolic changes
occur. Burns produce hypermetabolic and hypercatabolic
responses, which are related to the extent and depth of the
injuries (9). Burns affecting .20% of the body surface cause
a major loss of extracellular fluids, thereby inducing shock
by increasing vascular permeability and reducing plasma
albumin from the wound exudations. Hypoalbuminemia
also causes complications related to increasing extravascular
fluids, including edema, abnormalities in healing, and
increased susceptibility to sepsis (10). However, it is unclear
whether hypoalbuminemia can be used as a predictor of
mortality. Therefore, we investigated whether hypoalbumi-
nemia could predict mortality in burn patients.
& MATERIALS AND METHODS
Design
We performed a retrospective cross-sectional study of
burn patients admitted to the Burn Unit of the Specialties
Hospital of the Western National Medical Center in
Guadalajara, Mexico, from January 2009 to December 2011.
During this 36-month period, we included individuals
older than 16 years of age who were diagnosed with burns
within 24 hours after injury (regardless of the causative
agent, location, or thickness of the burn) and who had
complete clinical documentation. We excluded patients
with insufficient information to analyze the appropriate
variables and patients suffering end-stage kidney disease,
nephrotic syndrome, chronic liver disease, or inflammatory
bowel disease, or were undernourished. The variables
examined were age, gender, causal agent, occupation, site
of injury, burned BSA, full-thickness burns, and inhalation
burns; laboratory test results, such as hemoglobin, hemato-
crit, total leukocytes, lymphocytes, neutrophils, platelet
count, blood glucose, urea, creatinine, cholesterol, serum
total proteins, albumin, and globulin at admission to the
Burn Unit, were also examined. The calculation of the burn
BSA was based on the ‘‘rule of nines’’. This system is useful
for rapidly assessing adults, and second- and third-degree
burns were included and corrected according to the Lund–
Browder scheme (11). Albumin levels were considered to be
both a quantitative variable and an ordinal variable and
were divided into three groups: .3 g/dL, 2–3 g/dL, and
,2 g/dL. Inhalation injury was diagnosed by direct
laryngoscopy and/or bronchoscopy based on positive
findings of redness, mucosal edema, ash particles, and
vascular injection in addition to evidence of burns to the
face, enclosed spaces, and nasal vibrissae.
Full-thickness burns were defined as third-degree burns
that involved the destruction of the entire thickness of
the epidermis and dermis, including the appendices.
These burns were stiff and whitish in appearance and
presented with blood vessel coagulation and sensory nerve
destruction; edema was present below the damaged tissue
despite the scarring. We defined ‘‘expected mortality’’ as
the probability of death according to the ABSI scale, and
‘‘observed mortality’’ as the percentage of deaths in the
population.
Statistical analysis
The descriptive phase of the analysis included the
presentation of data as raw proportions, means, and standard
deviations. The Student’s t-test was used to compare the
quantitative variables, and a x2 test was used for the
qualitative variables. A univariate analysis was performed
to determine the odds ratios (OR) and 95% confidence
intervals (CIs), and an analysis of the sensitivity and
specificity for the quantitative variables was conducted. The
cut-off points at which the levels of serum albumin, globulin,
total proteins, cholesterol, and triglycerides (TG) established
a sensitivity and specificity of 80% were determined, and
p,0.05 was considered significant. Microsoft Excel 2007
(Redmond, WA, USA) and SPSS for Windows (version 17;
IBM, Armonk, NY, USA) were used for data processing and
statistical analysis. The protocol was approved by the Local
Committee on Health Research, code 2008-1301-77.
& RESULTS
During the study period, 652 patients were admitted, 486
of whom met the inclusion criteria for this study. The
remaining 166 patients were excluded because of previous
treatment in another hospital or burn unit, associated
morbidity, unavailability for follow-up because of transfer
to another medical unit, and/or incomplete medical
records. Most of the patients were male (373 cases, 76.7%),
and 113 were female (23.3%). The patients ranged in age
from 22 to 56 years (average age, 38.9¡16.6 years), and
65.6% were married. The accident occurred in the workplace
Table 1 - Characteristics of the burn injuries in 486
patients.
Causative agent No. of patients %
Flame 246 50.6
Electricity 130 26.7
Scalding 84 17.3
Others 26 5.3
,30% of body surface affected 404 83.1
.30% of body surface affected 82 16.9
Full-thickness 156 32.1
Injury caused by inhalation 61 12.6
Table 2 - Expected and observed mortality according to the ABSI scale (n=486).
ABSI points Affected n (%) Observed mortality n (%) Expected mortality %
2–3 90 (18.6) 0 ,1
4–5 215 (44.2) 1 (0.46) 2
6–7 115 (23.7) 12 (10.4) 10–20
8–9 38 (7.8) 4 (10.5) 30–50
10–11 16 (3.2) 10 (62.5) 60–80
12–13 12 (2.4) 8 (66.6) .90
ABSI, Abbreviated Burn Severity Index.
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in 51.9% of cases and at home in 33.5%; the remainder
(14.6%) occurred as a result of traffic accidents, sporting
events, or during school hours. The characteristics, causes,
extents, and depths of the lesions are described in Table 1.
Most individuals had burns to #30% of their BSA (83.1%),
and .30% of the BSA was affected in 16.9% of patients. The
most common causative agent was flame (50.6%). The
expected mortality according to the ABSI scale is described
in Table 2. Mortality was observed in 35 patients (7.2%)
during the study period. One patient with an ABSI score in
the 4–5 range died, although the expected mortality was
only 2%. Of the remaining 34 non-surviving patients, those
with scores exceeding 8–9 had an expected mortality of up
to 50% but an observed mortality of only 10.5%. In patients
with scores .12, the expected mortality was .90%, and the
observed mortality was 66.6%. The ABSI scores upon
admission were 9.37¡2.59 in the patients who died and
5.02¡1.8 in those who survived.
Table 3 presents the results of a univariate analysis of the
qualitative data. No statistically significant difference was
observed between patients younger and older than 40 years
or in relation to gender, marital status, or occupation. The
highest mortality was observed in the following cases: the
burn causative agent was flame, full-thickness burns, the
injury resulted from inhalation, and the serum albumin
level was ,2 g/dL. Table 4 presents the results of the
analysis of the quantitative variables. The average affected
BSA in the patients who died was 49.71¡24.28% vs.
14.72¡13.32% for survivors. There were also significant
differences in the levels of cholesterol, TG, albumin,
globulin, and total proteins, and in the albumin/globulin
ratio, between the patients who survived and those who
died. The levels of hemoglobin, hematocrit, lymphocytes,
neutrophils, platelets, glucose, urea, or creatinine in patients
who died did not differ significantly from those of the
survivors. Figure 1 shows the receiver-operating character-
istic (ROC) curves comparing the quantitative variables of
the burn patients upon admission to the specialized
management unit that differed significantly (albumin,
globulin, total proteins, cholesterol, TG, and the albumin/
globulin ratio). The greatest area under the ROC curve was
observed for albumin (0.869), followed by serum proteins,
cholesterol, and TG. Using a cut-off point of 1.95 g/dL
albumin, the sensitivity of albumin in predicting mortality
was 84%, and the specificity was 83.3%. For all patients,
20.6% had albumin levels ,2 g/dL, 38.7% had levels of 2–
3 g/dL, and 40.7% had levels .3 g/dL.
The mean hospital stay was 25.2¡30.7 days (range, 4–251
days). Forty-five patients required ventilatory support
because of inhalation injury or progressive respiratory failure
caused by multiple organ failure, hypovolemic shock, or
massive pulmonary embolism. The average intensive care
unit stay of patients with ventilatory support was 38.9 days.
Early mortality (,7 days) was observed in 13 patients and
attributed to multiple organ failure or hypovolemic shock.
These patients all suffered inhalation burns.
Table 3 - Univariate analysis.
Survived Died p-value OR (95% CI)
Age (years)
.40 283 19 0.31 1.42 (0.6–2.9)
,40 168 16 0.31
Gender
Male 350 23 (6.19%) 0.10 1.81 (0.8–3.9)
Female 101 12 (10.6%)
Marital status
Married 296 23 0.99 1 (0.4–2.1)
Other 155 12
Occupation
Employee 238 14 0.14 1.6 (0.7–3.5)
Other 213 21
Burn agent
Flame 221 30 0.003 2.7 (1.2–5.7)
Others 230 5
Full-thickness
No 314 16 0.004 2.7 (1.2–5.7)
Yes 137 19
Inhalation burns
No 406 19 0.000 7.6 (3.4–16.8)
Yes 45 16
Serum albumin
,2 g/dL 71 29 0.000 25.8 (9.7–72.3)
.2 g/dL 380 6
OR, odds ratio; 95% CI, 95% confidence interval.
Table 4 - Analysis of quantitative variables.
Survivors (n=451) Deceased patients (n=35) *p-value
Age (years) 38.7¡16.6 41.9¡16.6 0.269
Body surface burned (%) 14.7¡13.3 49.7¡24.4 0.000
ABSI at admission 5.0¡1.8 9.3¡2.5 0.000
Hemoglobin 14.2¡2.4 13.9¡4.4 0.672
Hematocrit 40.7¡6.4 39.9¡11.9 0.697
Leucocytes 15,823.2¡17,985.8 18,068.2¡11,717.1 0.468
Total lymphocytes 2,582.6¡4,155.4 2,130.9¡2,953.7 0.529
Total neutrophils 10,741.5¡11,661.6 12,316.7¡9,917.5 0.437
Platelets 240,266¡90,843.4 257,800¡154,504.6 0.512
Glucose 124.0¡91.2 145.2¡76.3 0.181
Urea 41.9¡83.2 64.7¡103.3 0.212
Creatinine 0.9¡1.0 1.1¡1.2 0.273
TC 144.5¡71.6 111.3¡54.6 0.011
TG 144.7¡101.0 187.5¡152.5 0.032
Globulin 2.8¡0.5 1.5¡0.6 0.000
Albumin 2.8¡0.8 1.5¡0.7 0.000
TP 5.6¡1.1 3.7¡1.2 0.000
*p-value according to Student’st-test.
ABSI, Abbreviated Burn Severity Index; TC, total cholesterol; TG, triglycerides; TP, total proteins.
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Late mortality was observed in 22 patients, 12 of whom
died of multiple organ failure, eight of progressive respira-
tory failure, and the remaining two as a consequence of
massive pulmonary embolism.
& DISCUSSION
The overall mortality in our series was 7.2%. According to
the ABSI scores at admission, mortality was overestimated
for the patients with ABSI scores of 4–5, 8–9, and .12. Our
results contrast with those reported by Lionelli et al., who
found that the ABSI score was strongly predictive for
mortality (p,0.0001), with a 200% average increase in
mortality per unit increase in ABSI (12). Therefore, the
expected values overestimate the actual mortality values. To
address these discrepancies, some investigators have sought
the prognostic value of different scales by simplifying them
(13–17) or by increasing the difficulty of obtaining results
with more complex calculations (18–20). Because the most
important function of albumin is to maintain an oncotic
pressure of at least 80% of the normal level, its reduction
could induce complications that predispose patients to
malnutrition, the loss of immune responses, and an
increased risk of infection (21). Several studies have shown
the deleterious effects of hypoalbuminemia in terms of
hospital stay, morbidity, and mortality in patients with
various conditions, including critically ill patients or those
patients undergoing chronic renal replacement therapy and
surgical patients (22–24). Recently, Ramos et al. (25) found
that severe hypoalbuminemia (,2 g/dL), which was
observed in 15 of the 73 burn patients (20%), was strongly
associated with an increase in the affected BSA (p,0.001),
greater burn severity (according to the Benaim classification,
p,0.001), and a higher mortality rate (33% vs. 0%). These
authors concluded that serum albumin level can be used as
a marker for trauma severity and as a biological marker for
the different stages of evolution of severely burned patients.
In contrast, in a cross-sectional study with fewer patients,
Miquet-Romero et al. reported a mortality rate of ,10% in
severely burn patients (2/23) in whom hypoalbuminemia
was frequently observed, demonstrating a significant
association between the extent of the burn and the serum
albumin level. However, these authors found no relation-
ship between the level of this protein and hospital stay,
complication rate, or mortality (26). Despite the conflicting
views of the previously mentioned studies, Kim et al. (who
conducted a cross-sectional analysis of 147 burn patients)
showed that albumin level predicted not only mortality but
also the risk of developing kidney failure, which eventually
resulted in 100% mortality in the 28 patients who developed
this complication (27). Eljaiek and Dubois performed
another cross-sectional study of 56 burned patients with a
total burn size (TBS) of 30.3¡10.9%, 36 (64.3%) patients had
hypoalbuminemia (,30 g/L) and 20 (35.7%) had albumin
levels .30 g/L (28). The authors demonstrated that the
presence of hypoalbuminemia in the first 24 hours after
injury was an independent predictor of organ dysfunction.
They observed no mortality in the patients with normal
albumin levels but 16.7% mortality in patients with
hypoalbuminemia. However, the difference was not statis-
tically significant, likely because the sample size was small.
We also examined the relationships between mortality and
the levels of other serum proteins and lipids. The sensitivity
and specificity of total serum proteins, globulin, the
albumin/globulin ratio, cholesterol, and TG were inferior to
those of albumin in predicting mortality. In another cross-
sectional study, Papadopoulos et al. (29) demonstrated that
the mean cholesterol levelof the patients who died was lower
Figure 1 - Receiver-operating characteristic (ROC) curves. Albumin=0.861, total protein=0.853, albumin/globulin ratio=0.837,
globulin= 0.755, cholesterol = 0.734, and triglycerides = 0.373.
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than that of the surviving patients when the TBS was .30%.
However, the authors did not evaluate the relationship
between serum proteins and mortality.
Our data showed that albumin levels may be useful in
predicting mortality in burn patients. These skin injuries
induce a strong inflammatory response and the release of
vasoactive substances, which increases the skin permeabil-
ity to water, albumin, and even larger protein molecules
(21,30–32). This process peaks during the first 12–24 hours,
coupled with a reduction in the albumin mRNA response to
the burn and an increased synthesis and accumulation of
acute-phase reactants. After this initial phase, hypoalbumi-
nemia persists because of the lack of its synthesis, its loss
through damaged skin areas, and deficiencies in nutritional
support (33–35). In our patients, hypoalbuminemia was
closely related to the burned BSA, which is considered to
have predictive value for mortality. Both events are closely
related. The albumin level is the only modifiable factor
related to outcomes because albumin levels can be corrected
by administering human albumin solutions (HAS), which
have been used for either fluid resuscitation or hypoalbu-
minemia correction. Few studies have assessed the use of
HAS for fluid resuscitation in severely burned patients.
Initially, a meta-analysis showed increased mortality in the
burn patients resuscitated with HAS (36–39). Melinyshyn
et al. (40) recently published the results of a cross-sectional
study of two groups of burn patients treated with either
albumin infusions to maintain their serum albumin con-
centrations above 2 g/L or with standard solutions after the
resuscitation phase. The authors could not demonstrate any
difference in the wound healing, length of hospital stay, or
mortality. They concluded that routine supplementation
with 5% HAS to maintain the serum albumin levels of burn
patients above 2 g/L was expensive and provided no extra
benefit.
Another clinical trial and a systematic review showed
neutral effects (41–45). However, the efficacy of hypoalbu-
minemia correction can be extrapolated from studies
performed in other types of critically ill patients. A recent
meta-analysis found that using albumin-containing solu-
tions to resuscitate septic patients was associated with lower
mortality than other fluid resuscitation treatments (46).
In addition to its well-known oncotic properties, albumin
has many other physiological roles that might support
hypoalbuminemia correction in critically ill patients, such as
the binding of endogenous and exogenous substances,
anticoagulant effects, maintenance of acid–base status,
modulation of apoptosis, and protective effects on the
microcirculation (47).
Another issue to consider is the role of nutritional
support. The best possible nutrition and nutritional route
for each individual must be guaranteed. Enteral nutrition
is preferable, but if this treatment cannot provide the
minimum requirements to halt the catabolic phase, induce
the anabolic phase, or cannot be used for any reason, then
the parenteral route or combined enteral/parenteral
routes should be used to ensure the provision of
macronutrients (specifically proteins) in higher than
normal quantities (36).
For this strategy to succeed, the modulation of the
inflammatory response, immune strengthening, and the
optimal management of burned skin extensions is required
in addition to nutritional support to avoid immediate and
late protein leakage.
Our study suggests that hypoalbuminemia has a deleter-
ious effect on patient survival but does have some
limitations. Therefore, we suggest that a prospective cohort
study be conducted to confirm the association between
hypoalbuminemia and the risk of death and that more
multicenter prospective clinical trials be performed to
establish the benefits of HAS infusion in the early and late
phases of burn patient management. The outcome variables
should include not only the main outcome variable of
mortality and the presence or absence of infections and
organ failure but also the inflammatory response.
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